SecBot SecBot
8-K ·Filed Nov 16, 2026

MTRI

InMed Pharmaceuticals Inc.
NEUTRAL
Impact 6/10
Processed20h 23m ago SEC0001193125-26-462017
8-K material event: Items 2.01

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-462017
Document: d169852dex992.htm0001193125-26-462017
Document: d169852d8k.htm0001193125-26-462017
Document: 0001193125-26-462017-index-headers.html0001193125-26-462017
Document: 0001193125-26-462017-index.html0001193125-26-462017
Document: 0001193125-26-462017.txt0001193125-26-462017
8-K Data (Synthetic)0001193125-26-462017

US Market Status

Market Closed · Opens in 6h 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 16, 2026

Fresh MTRI Intelligence

Analysis is for subscribers only.

Subscribe for Full Access